Urinary Tumor Markers Could Predict Survival in Bladder Carcinoma
- 2 October 2012
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 28 (3) , 265-271
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder CancerAdvances in Urology, 2012
- E-Cadherin Tissue Expression and Urinary Soluble Forms of E-Cadherin in Patients with Bladder Transitional Cell CarcinomaUrologia Internationalis, 2008
- Preoperative Plasma Soluble E-Cadherin Predicts Metastases to Lymph Nodes and Prognosis in Patients Undergoing Radical CystectomyJournal of Urology, 2003
- The Addition of Urinary Urokinase-Type Plasminogen Activator to Urinary Nuclear Matrix Protein 22 and Cytology Improves the Detection of Bladder CancerJournal of Urology, 2003
- Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosisOncogene, 2002
- Comparative Evaluation of the Nuclear Matrix Protein, Fibronectin, Urinary Bladder Cancer Antigen and Voided Urine Cytology in the Detection of Bladder TumorsJournal of Urology, 2002
- DNA topoisomerase IIα predicts progression‐free and overall survival in pediatric malignant non‐brainstem gliomasInternational Journal of Cancer, 2002
- Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladderBJU International, 1999
- Towards a Comprehensive Database of Proteins From the Urine of Patients With Bladder CancerJournal of Urology, 1996
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978